As another COVID-19 summer surge hit the US this year, many infected people likely were prescribed the antivirals nirmatrelvir and ritonavir, better known as Paxlovid, for the first time. Or for the fourth time. Or somewhere in between. Nirmatrelvir-ritonavir, the only approved oral...
COVID-19This Medical News story examines the latest information about rebound, treatment eligibility, optimal dosing, and other questions related to nirmatrelvir-ritonavir for treating COVID-19.Rubin, RitaJAMA: Journal of the American Medical Association...
FullText Anyone who watches television has probably seen the Pfizer commercial with the tagline, “If it’s COVID, Paxlovid.” That might be a catchy slogan, but, apparently, a lot of people aren’t getting the message. The US Food and Drug Administration (FDA)approvedPaxlovid last May f...
Health and Science Pfizer to price Covid drug Paxlovid at $1,390 per course Wed, Oct 18th 2023 Finance Morgan Stanley shares fall over 6% as wealth management results disappoint Thu, Oct 19th 2023 Finance Bank of America tops profit estimates on better-than-expected interest income Thu, ...
Pfizer swings to loss due to Paxlovid, Covid vaccine write-offs Tue, Oct 31st 2023 Health and Science Pfizer's combination Covid, flu vaccine shows positive trial data Thu, Oct 26th 2023 CNBC Travel He visited every country in the world — without flying. Here's how much it cost Thu,...
John McLaughlin, PhD, examines high-risk individuals with prior SARS-CoV-2 immunity and presents that Paxlovid reduces the risk of hospitalization, death, and severe symptoms, highlighting its ongoing value for high-risk patients in a post-peak pandemic landscape. ...
The US Food and Drug Administration (FDA) approved Paxlovid last May for the treatment of mild to moderate COVID-19 in adults who are at risk of progression to severe disease. But it has been available since early 2022 under Emergency Use Authorization (EUA) from the FDA for treating COVI...
Access early treatment like Paxlovid if you are diagnosed Needless to say, COVID isn’t going away anytime soon. Being diligent about getting vaccinated and following prevention measures are the best way to keep you and your loved ones as healthy as possible—while still carrying on with your...
Information resource for gene therapy news, clinical trials, guidelines, regulation, literature, databases, background and educational information, scientific r
"We've got lots of people vaccinated and boosted. That's making a big difference," Jha said. "Then, we've done a lot of work to try to get Paxlovid out there. This is the oral pill that makes a big difference keeping people out of the hospital. I do think that that is what'...